cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas

Journal of Clinical Investigation

Volumn 116, Issue 1, 2006, Pages 174-181

  Hu, Shimin ^a   Du, Ming Qing ^b   Park, Sun Mi ^c   Alcivar, Allison ^a   Qu, Like ^a   Gupta, Sanjeev ^a   Tang, Jun ^a   Baens, Mathijs ^d   Ye, Hongtao ^b   Lee, Tae H ^c   Marynen, Peter ^d   Riley, James L ^a   Yang, Xiaolu ^a,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Yonsei University   (South Korea)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BCL 10; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME DEGRADATION; FEMALE; HUMAN; HUMAN CELL; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

CASPASES; CELL LINE; CYTOKINES; GENE FUSION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; NEOPLASM PROTEINS; RECOMBINANT FUSION PROTEINS; TRANSLOCATION, GENETIC;

EID: 31044455309     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI25641     Document Type: Article

References (40)

1. Deveraux, Q.L., and Reed, J.C. 1999. IAP family proteins: suppressors of apoptosis. Genes Dev. 13:239-252.
2. Salvesen, G.S., and Duckett, C.S. 2002. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3:401-410.
3. Deveraux, Q.L., et al. 1998. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17:2215-2223.
4. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 102:33-42.
5. Verhagen, A.M., et al. 2000. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 102:43-53.
6. Srinivasula, S.M., et al. 2001. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature. 410:112-116.
7. Yang, Y., Fang, S., Jensen, J.P., Weissman, A.M., and Ashwell, J.D. 2000. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science. 288:874-877.
8. Hu, S., and Yang, X. 2003. Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J. Biol. Chem. 278:10055-10060.
9. Vaux, D.L., and Silke, J. 2005. IAPs, RINGs and ubiquitylation. Nat. Rev. Mol. Cell Biol. 6:287-297.
10. Li, X., Yang, Y., and Ashwell, J.D. 2002. TNF-RII and c-IAP1 mediate ubiquitination and degradation of Traf2. Nature. 416:345-349.
11. Isaacson, P.G., and Du, M.Q. 2004. MALT lymphoma: from morphology to molecules. Nat. Rev. Cancer. 4:644-653.
12. Cavalli, F., Isaacson, P.G., Gascoyne, R.D., and Zucca, E. 2001. MALT lymphomas. Hematology (Am. Soc. Hematol. Educ. Program). 2001:241-258.
13. Zhang, Q., et al. 1999. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat. Genet. 22:63-68.
14. Willis, T.G., et al. 1999. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 96:35-45.
15. Sanchez-Izquierdo, D., et al. 2003. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood. 101:4539-4546.
16. Streubel, B., et al. 2003. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood. 101:2335-2339.
17. Uren, A.G., et al. 2000. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell. 6:961-967.
18. Dierlamm, J., et al. 1999. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood. 93:3601-3609.
19. Akagi, T., et al. 1999. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene. 18:5785-5794.
20. Morgan, J.A., et al. 1999. Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res. 59:6205-6213.
21. Ruland, J., et al. 2001. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell. 104:33-42.
22. Xue, L., et al. 2003. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat. Immunol. 4:857-865.
23. Ruland, J., Duncan, G.S., Wakeham, A., and Mak, T.W. 2003. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity. 19:749-758.
24. Ruefli-Brasse, A.A., French, D.M., and Dixit, V.M. 2003. Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase. Science. 302:1581-1584.
25. Lucas, P.C., et al. 2001. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J. Biol. Chem. 276:19012-19019.
26. Zhou, H., et al. 2004. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature. 427:167-171.
27. Sun, L., Deng, L., Ea, C.K., Xia, Z.P., and Chen, Z.J. 2004. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell. 14:289-301.
28. Hayden, M.S., and Ghosh, S. 2004. Signaling to NF-kappaB. Genes Dev. 18:2195-2224.
29. Zhou, H., Du, M.Q., and Dixit, V.M. 2005. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell. 7:425-431.
30. Ye, H., et al. 2003. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood. 102:1012-1018.
31. Maes, B., Demunter, A., Peeters, B., and De Wolf-Peeters, C. 2002. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression. Blood. 99:1398-1404.
32. Ye, H., et al. 2005. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J. Pathol. 205:293-301.
33. Ye, H., et al. 2000. BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. Am. J. Pathol. 157:1147-1154.
34. Thome, M., et al. 2001. Equine herpesvirus protein E10 induces membrane recruitment and phosphorylation of its cellular homologue, bcl-10. J. Cell Biol. 152:1115-1122.
35. Scharschmidt, E., Wegener, E., Heissmeyer, V., Rao, A., and Krappmann, D. 2004. Degradation of Bcl10 induced by T-cell activation negatively regulates NFkappa B signaling. Mol. Cell. Biol. 24:3860-3873.
36. Parry, R.V., Rumbley, C.A., Vandenberghe, L.H., June, C.H., and Riley, J.L. 2003. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes. J. Immunol. 171:166-174.
37. Willis, T.G., and Dyer, M.J. 2000. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood. 96:808-822.
38. Duan, L., Reddi, A.L., Ghosh, A., Dimri, M., and Band, H. 2004. The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling. Immunity. 21:7-17.
39. Liu, H., et al. 2001. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood. 98:1182-1187.
40. Park, S.M., Yoon, J.B., and Lee, T.H. 2004. Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro. FEBS Lett. 566:151-156.